---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-003717"
form_type: "8-K"
ticker: "FEED"
cik: "0001326706"
company_name: "ENvue Medical, Inc."
filed_at: "2025-04-11T23:59:59+00:00"
generated_at: "2026-05-23T15:56:45.743239+00:00"
event_type: "debt"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# NanoVibronix subsidiary issues $360K note; Nasdaq confirms compliance

## Summary
- ENvue Medical Holdings issued $360K promissory note to Alpha Capital Anstalt, 8% interest, maturity June 11, 2025.
- NanoVibronix fully guarantees subsidiary's obligations under the note.
- Nasdaq confirmed company regained minimum bid price and equity compliance; subject to one-year mandatory panel monitor.
- If non-compliance during monitoring, no plan permitted; delist determination will be issued immediately.

## SEC filing metadata
- accession: 0001641172-25-003717
- form_type: 8-K
- ticker: FEED
- cik: 0001326706
- company_name: ENvue Medical, Inc.
- filed_at: 2025-04-11T23:59:59+00:00
- event_type: debt
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 2.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1326706/000164117225003717/0001641172-25-003717-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1326706/000164117225003717/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-003717
- JSON: https://secwatch.observer/filing/0001641172-25-003717.json
- Plain text: https://secwatch.observer/filing/0001641172-25-003717.txt

## Key facts
- Debt Financings
  ENvue Medical, Inc. incurred guarantee of all obligations and liabilities of ENvue under the Note with Alpha Capital Anstalt at not specified maturing not specified.
  - Instrument: guarantee
  - Principal: all obligations and liabilities of ENvue under the Note
  - Counterparty: Alpha Capital Anstalt
  - Rate: not specified
  - Maturity: not specified
  - Event: incurrence
  source text: In connection with ENvue’s issuance of the Note, on April 11, 2025, the Company entered into that certain Guaranty (the “ Guaranty ”) in favor of the Lender, pursuant to which the Company has agreed to guarantee to the Lender the payment of all obligations and liabilities of ENvue under the Note, including, without limitation, for principal, interest and any other amounts due and payable by ENvue under the Note (the “ Guaranteed Obligations ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1326706/000164117225003717/0001641172-25-003717-index.htm
- Debt Financings
  ENvue Medical, Inc. incurred loan of $360,000 with Alpha Capital Anstalt at 8.0% per annum maturing June 11, 2025.
  - Instrument: loan
  - Principal: $360,000
  - Counterparty: Alpha Capital Anstalt
  - Rate: 8.0% per annum
  - Maturity: June 11, 2025
  - Event: incurrence
  source text: On April 11, 2025, ENvue Medical Holdings, Corp. (“ ENvue ”), a wholly-owned subsidiary of NanoVibronix, Inc. (the “ Company ”), issued a promissory note (the “ Note ”) to Alpha Capital Anstalt (the “ Lender ”) in the principal amount of $360,000 (the “ Principal Amount ”), together with all accrued interest thereon.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1326706/000164117225003717/0001641172-25-003717-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.